ReviewClinical neurophysiology practice2026
Home-based transcranial static magnetic field stimulation - concept, development, and clinical applications: IFCN handbook chapter.
Review in Clinical neurophysiology practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), have significantly advanced neuroscience research and clinical practice. However, these approaches can involve costly equipment (particularly TMS) and varying degrees of technical complexity, especially for protocols requiring precise targeting. Transcranial static magnetic field stimulation (tSMS) has recently emerged as a novel, accessible alternative. This technique uses a simple, constant magnetic field-typically generated by a neodymium magnet-to modulate cortical excitability without electrical input, or perceptible sensation. While static magnets have long been associated with pseudoscientific practices, rigorous studies since 2011 have established the physiological effects of tSMS, demonstrating its capacity to transiently reduce cortical excitability in humans. The simplicity, portability, and excellent safety profile of tSMS make it especially well-suited for home-based applications and long-duration protocols. Although its modulatory effects tend to be modest and transient, recent research indicates that longer stimulation durations can extend the effects, and its predominantly inhibitory action may be advantageous for specific clinical targets. While the static nature of the magnetic field limits depth penetration, ongoing innovations may help address this constraint. Overall, tSMS represents a low-cost, well-tolerated, and practical addition to the NIBS toolkit, with growing potential to support individualized neuromodulation strategies in both research and therapeutic settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.